Popular weight-loss drugs show promise in reducing kidney disease complications and mortality
A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...
Review links 3 potentially-blinding eye conditions to GLP-1 drugs like Ozempic
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.
Today's Dietitian8h
What’s the Mechanism Behind Behavioral Side Effects of Weight Loss Drugs?
GLP1RA mimic the GLP-1 hormone in the body that helps control insulin and blood glucose levels and promotes feelings of satiety. GLP-1 binds to GLP1R on cells in the brain and pancreas.
Pharmaceutical Technology on MSN8h
Super Bowl ad for copycat weight loss drugs stokes pharma power debate
Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting event.
Endocrinology Advisor18h
GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of Treatment
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.